Medicare Enrolled
Dr. Phu Tran, M.D.
Hematology & Oncology · Port St Lucie, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tran? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tran
Dr. Phu Tran is a hematology & oncology in Port St Lucie, FL, with 14 years in practice. Based on federal Medicare data, Dr. Tran performed 112,342 Medicare services across 5,016 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tran received a total of $17,485 from 60 pharmaceutical and/or device companies across 626 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tran is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice▲ Top 6% volume in FL$ $17,485 industry payments
Medicare Practice Summary
Medicare Utilization ↗112,342
Medicare services
Top 6% in FL for hematology & oncology
5,016
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,024 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 29,580 | $0 | $2 |
| Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 22,380 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 17,800 | $42 | $91 |
| Filgrastim injection (Nivestym) for white blood cells | 10,620 | $0 | $2 |
| Paclitaxel chemotherapy injection | 5,470 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 4,750 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 4,560 | $18 | $30 |
| Dexamethasone injection (steroid) | 2,841 | $0 | $1 |
| Complete blood count (CBC) with differential | 1,565 | $8 | $30 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,260 | $1 | $10 |
| Blood draw (venipuncture) | 1,104 | $8 | $15 |
| Epoetin alfa injection (Procrit) for anemia | 1,020 | $6 | $20 |
| Epoetin alfa injection (Retacrit) for anemia | 1,000 | $6 | $24 |
| Office visit, established patient (20-29 min) | 665 | $68 | $210 |
| Office visit, established patient (30-39 min) | 531 | $104 | $300 |
| Injection, leucovorin calcium, per 50 mg | 442 | $3 | $10 |
| Hospital follow-up visit, moderate complexity | 434 | $66 | $165 |
| Basic metabolic blood panel | 408 | $8 | $25 |
| Administration of chemotherapy into vein, 1 hour or less | 358 | $105 | $330 |
| Ferritin level test (iron stores) | 349 | $13 | $40 |
| Anti-nausea injection (ondansetron/Zofran) | 344 | $0 | $2 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 339 | $24 | $85 |
| Drug injection, under skin or into muscle | 316 | $11 | $40 |
| Injection of additional new drug or substance into vein | 297 | $13 | $55 |
| Iron level test | 284 | $6 | $20 |
| Iron binding capacity test | 282 | $9 | $25 |
| Injection, carboplatin, 50 mg | 247 | $2 | $10 |
| Comprehensive metabolic blood panel | 232 | $10 | $30 |
| Injection, magnesium sulfate, per 500 mg | 158 | $1 | $2 |
| Injection, diphenhydramine hcl, up to 50 mg | 155 | $1 | $4 |
| Injection, fluorouracil, 500 mg | 151 | $2 | $10 |
| Lactate dehydrogenase (enzyme) level | 142 | $6 | $20 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 136 | $59 | $125 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 132 | $52 | $150 |
| New patient office visit (45-59 min) | 132 | $123 | $390 |
| Administration of additional new drug or substance into vein, 1 hour or less | 131 | $53 | $165 |
| Infusion into a vein for hydration, each additional hour | 128 | $10 | $40 |
| Initial hospital admission, high complexity | 128 | $145 | $460 |
| Vitamin B-12 level test | 121 | $15 | $50 |
| Infusion, normal saline solution , 1000 cc | 109 | $2 | $10 |
| Administration of chemotherapy into vein, each additional hour | 85 | $23 | $80 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 83 | $1 | $6 |
| Infusion into a vein for hydration, 31-60 minutes | 82 | $25 | $125 |
| Folic acid level test | 79 | $14 | $55 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 79 | $1 | $4 |
| Prothrombin time test (blood clotting) | 73 | $4 | $15 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 68 | $3 | $10 |
| Liver function blood test panel | 56 | $8 | $25 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 48 | $400 | $681 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 48 | $4 | $12 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 45 | $1,194 | $5,700 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 44 | $16 | $50 |
| Carcinoembryonic antigen (cea) protein level | 42 | $19 | $55 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 40 | $25 | $85 |
| Irrigation of implanted venous access drug delivery device | 37 | $20 | $55 |
| Ct scan of chest with contrast | 32 | $48 | $700 |
| Ct scan of abdomen and pelvis before and after contrast | 31 | $199 | $1,450 |
| Anticoagulant management of patient taking warfarin | 31 | $9 | $25 |
| Blood creatinine level | 30 | $5 | $15 |
| Urea nitrogen level to assess kidney function, quantitative | 30 | $4 | $7 |
| Magnesium level test | 28 | $7 | $20 |
| New patient office visit, complex (60-74 min) | 23 | $176 | $520 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 22 | $20 | $60 |
| Manual urinalysis test with examination using microscope, non-automated | 21 | $4 | $20 |
| Administration of additional new drug or substance into vein using push technique | 21 | $46 | $140 |
| Drawing of blood for a medical problem | 21 | $78 | $165 |
| PSA test (prostate cancer screening) | 19 | $18 | $75 |
| Collection of blood sample from implanted device | 12 | $22 | $50 |
| Stool analysis for blood, by peroxidase activity | 11 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.1% high complexity
66.5% medium
6.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,485
Total received (2018-2024)
Avg $2,498/year across 7 years
Top 28% in FL for hematology & oncology
60
Companies
626
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,962 (57.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,248 (30.0%)
Other
Charitable contributions, space rental, and other categories
$1,665 (9.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$609 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$7,745
2023$3,801
2022$2,945
2021$2,446
2020$396
2019$120
2018$32
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,948
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,716
Novartis Pharmaceuticals Corporation
$1,671
PFIZER INC.
$1,025
Incyte Corporation
$611
Janssen Biotech, Inc.
$569
Merck Sharp & Dohme LLC
$541
GENZYME CORPORATION
$511
Celgene Corporation
$436
Regeneron Healthcare Solutions, Inc.
$420
Seagen Inc.
$351
Lilly USA, LLC
$326
GlaxoSmithKline, LLC.
$299
Mirati Therapeutics, Inc.
$276
Takeda Pharmaceuticals U.S.A., Inc.
$262
NOVARTIS PHARMACEUTICALS CORPORATION
$250
Genentech USA, Inc.
$237
Eisai Inc.
$227
ABBVIE INC.
$202
Novocure GmbH
$200
BeiGene USA, Inc.
$196
Daiichi Sankyo Inc.
$196
Astellas Pharma US Inc
$189
Amgen Inc.
$184
Merck Sharp & Dohme Corporation
$160
JAZZ PHARMACEUTICALS INC.
$155
Exelixis Inc.
$152
EISAI INC.
$141
Ipsen Biopharmaceuticals, Inc
$137
Medtronic, Inc.
$136
ARRAY BIOPHARMA INC
$134
Bayer HealthCare Pharmaceuticals Inc.
$129
PUMA BIOTECHNOLOGY, INC.
$125
E.R. Squibb & Sons, L.L.C.
$113
SOBI, INC
$113
Alexion Pharmaceuticals, Inc.
$107
Puma Biotechnology, Inc.
$96
AVEO Pharmaceuticals, Inc.
$89
Gilead Sciences, Inc.
$79
Bayer Healthcare Pharmaceuticals Inc.
$78
Aveo Pharmaceuticals, Inc.
$75
G1 Therapeutics, Inc.
$75
Karyopharm Therapeutics Inc.
$57
Sobi, Inc
$52
Pharmacyclics LLC, An AbbVie Company
$49
ACCORD HEALTHCARE, INC.
$41
EMD Serono, Inc.
$40
AbbVie Inc.
$38
Kite Pharma, Inc.
$31
Acceleron Pharma, Inc.
$31
Jazz Pharmaceuticals Inc.
$29
Dova Pharmaceuticals
$28
Amneal Pharmaceuticals LLC
$25
Novocure Inc.
$25
Azurity Pharmaceuticals, Inc.
$23
Tolmar, Inc.
$20
Sun Pharmaceutical Industries Inc.
$18
TAIHO ONCOLOGY, INC.
$17
Tempus AI, Inc
$16
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 42.0% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AVASTIN · BEVESPI AEROSPHERE · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · NERLYNX · NINLARO · Nplate · Nubeqa · OFEV · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Onivyde · Optune · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · Padcev · Phesgo · Pomalyst · Prolia · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · SARCLISA · SHINGRIX · Stivarga · TAGRISSO · TALVEY · TECENTRIQ · TECVAYLI · TUKYSA · Tazverik · Tecentriq · Truqap · ULTOMIRIS · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $16 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
24
Per 100K population
6.9
County median income
$69,027
Nearest hospital
ST LUCIE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tran is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tran experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Tran performed 29,580 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tran receive payments from pharmaceutical companies?
Yes. Dr. Tran received a total of $17,485 from 60 companies across 626 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tran's costs compare to other hematology & oncologys in Port St Lucie?
Dr. Tran's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Port St Lucie
Browse hematology & oncologys in Port St Lucie ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology